Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration
Journal of Endocrinological Investigation · 2024
DOI: 10.1007/s40618-024-02409-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2024. Verfasst von J C Galofré und 54 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pío XII, 36., 31080, Pamplona, Spain. jcgalofre@unav.es. Hauptthemen laut MEDLINE: Obesity, Thyroid Hormones, Practice Patterns, Physicians'. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Navarra.
Abstract (Originalsprache)
Purpose
The use of thyroid hormones (TH) to treat obesity is unsupported by evidence as reflected in international guidelines. We explored views about this practice, and associations with respondent characteristics among European thyroid specialists.
Methods
Specialists from 28 countries were invited to a survey via professional organisations. The relevant question was whether “ Thyroid hormones may be indicated in biochemically euthyroid patients with obesity resistant to lifestyle interventions” .
Results
Of 17,232 invitations 5695 responses were received (33% valid response rate; 65% women; 90% endocrinologists). Of these, 290 (5.1%) stated that TH may be indicated as treatment for obesity in euthyroid patients. This view was commoner among non-endocrinologists (8.7% vs. 4.7%, p < 0.01), private practice (6.5% vs. 4.5%, p < 0.01), and varied geographically (Eastern Europe, 7.3%; Southern Europe, 4.8%; Western Europe, 2.7%; and Northern Europe, 2.5%). Respondents from Northern and Western Europe were less likely to use TH than those from Eastern Europe (p < 0.01). Gross national income (GNI) correlated inversely with this view (OR 0.97, CI: 0.96–0.97; p < 0.001). Having national guidelines on hypothyroidism correlated negatively with treating obesity with TH (OR 0.71, CI: 0.55–0.91).
Conclusions
Despite the lack of evidence, and contrary to guidelines’ recommendations, about 5% of respondents stated that TH may be indicated as a treatment for obesity in euthyroid patients resistant to life-style interventions. This opinion was associated with (i) respondent characteristics: being non-endocrinologist, working in private practice, treating a small number of hypothyroid patients annually and (ii) national characteristics: prevalence of obesity, Eastern Europe, low GNI and lack of national hypothyroidism guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pío XII, 36., 31080, Pamplona, Spain. jcgalofre@unav.es.
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. jcgalofre@unav.es.
- Thyroid Task Force From the Sociedad Española de Endocrinología y Nutrición (SEEN), Madrid, Spain. jcgalofre@unav.es.
- Thyroid Task Force From the Sociedad Española de Endocrinología y Nutrición (SEEN), Madrid, Spain.
- Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
- Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, Madrid, Spain.
Förderung
- Universidad de Navarra
Zitieren
APA
Galofré, J. C., Díez, J. J., Attanasio, R., Nagy, E. V., Negro, R., Papini, E., Perros, P., Žarković, M., Akarsu, E., Alevizaki, M., Ayvaz, G., Bednarczuk, T., Beleslin, B. N., Berta, E., Bodor, M., Borissova, A. M., Boyanov, M., Buffet, C., Burlacu, M. C., …, & Hegedüs, L. (2024). Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02409-z
Vancouver
Galofré JC, Díez JJ, Attanasio R, Nagy EV, Negro R, Papini E, et al. Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration. Journal of Endocrinological Investigation. 2024. doi:10.1007/s40618-024-02409-z
BibTeX
@article{Galofr2024,
author = {Galofré, J C and Díez, J J and Attanasio, R and Nagy, E V and Negro, R and Papini, E and Perros, P and Žarković, M and Akarsu, E and Alevizaki, M and Ayvaz, G and Bednarczuk, T and Beleslin, B N and Berta, E and Bodor, M and Borissova, A M and Boyanov, M and Buffet, C and Burlacu, M C and Dobnig, H and Fadeyev, V and Field, B C T and Fliers, E and Führer, D and Hakala, T and Jiskra, J and Kopp, P and Krebs, M and Kršek, M and Kužma, M and Lantz, M and Lazúrová, I and Leenhardt, L and Luchytskiy, V and Puga, F M and McGowan, A and Metso, S and Moran, C and Morgunova, T and Niculescu, D A and Perić, B and Planck, T and Poiana, C and Robenshtok, E and Rosselet, P O and Ruchala, M and Riis, K R and Shepelkevich, A and Tronko, M and Unuane, D and Vardarli, I and Visser, W E and Vryonidou, M and Younes, Y R and Hegedüs, L},
title = {Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration},
journal = {Journal of Endocrinological Investigation},
year = {2024},
doi = {10.1007/s40618-024-02409-z}
}
EUVIMED